Coloplast A/SHere is the public summary page for Coloplast A/S. Please login to see the complete information for Coloplast A/S including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Coloplast A/S stacks up relative to its peers. |
Darwin Score | -5 |
Ticker | COLO_B |
Latest Price | 615.80 DKK as of close on 10-Jul-2025 |
3 Month price range | 594.80 to 736.19 DKK |
Market Capitalisation | 135.67Bn DKK |
Country | Denmark |
Region | Europe |
Economic Sector | Health Care |
Business Sector | Health Care Equipment & Services |
Industry | Health Care Equipment & Supplies |
Sub-Industry | Health Care Equipment |
Description | Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark. See More ... |
Company URL | https://www.coloplast.com |
See Darwins Full Analysis for Coloplast A/S |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Coloplast A/S. Further information and full detail is available when you login.
TMA Part | Focus of Analysis | TMA Score |
---|---|---|
Price | Analysis of performance, trend, RSI, OBV and moving averages | -12 |
Sentiment | News and Candle Patterns. | 0 |
Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +2 |
Flow | Institutional, Fund and Insider buying and selling. | 0 |
Models | Forecast models. | +5 |
Peer Comparison
There are 3 peers of Coloplast A/S.
Asset Name | Industry Group | Asset Score |
---|---|---|
Ambu A/S (AMBU_B) | Health Care Equipment | -25 |
Demant A/S (DEMANT) | Health Care Equipment | +12 |
GN Store Nord A/S (GN) | Health Care Equipment | -19 |